0001974912-23-000001.txt : 20230505 0001974912-23-000001.hdr.sgml : 20230505 20230505114305 ACCESSION NUMBER: 0001974912-23-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20230505 DATE AS OF CHANGE: 20230505 EFFECTIVENESS DATE: 20230505 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Violet Therapeutics, Inc. CENTRAL INDEX KEY: 0001974912 IRS NUMBER: 863656024 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-480940 FILM NUMBER: 23892160 BUSINESS ADDRESS: STREET 1: ONE MAIN STREET STREET 2: SUITE 510 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 508-344-2319 MAIL ADDRESS: STREET 1: ONE MAIN STREET STREET 2: SUITE 510 CITY: CAMBRIDGE STATE: MA ZIP: 02142 D 1 primary_doc.xml X0708 D LIVE 0001974912 Violet Therapeutics, Inc. ONE MAIN STREET SUITE 510 CAMBRIDGE MA MASSACHUSETTS 02142 508-344-2319 DELAWARE None None Corporation true 2021 Meredith Fisher c/o Violet Therapeutics, Inc. One Main Street, Suite 510 Cambridge MA MASSACHUSETTS 02142 Executive Officer Director Jonathan Behr c/o Violet Therapeutics, Inc. One Main Street, Suite 510 Cambridge MA MASSACHUSETTS 02142 Director Atsushi Usami c/o Violet Therapeutics, Inc. One Main Street, Suite 510 Cambridge MA MASSACHUSETTS 02142 Director William E Yelle c/o Violet Therapeutics, Inc. One Main Street, Suite 510 Cambridge MA MASSACHUSETTS 02142 Executive Officer Director Other Decline to Disclose 06b false 2023-04-20 false true false 0 11486624 7449960 4036664 false 4 0 0 0 false Violet Therapeutics, Inc. /s/ Meredith Fisher Meredith Fisher Chief Executive Officer 2023-05-05